Spravato is a nasal spray that is used together with medication taken by mouth or by itself to treat adults with depression that is resistant to other treatments. Spravato is also used to treat depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. Esketamine was granted “breakthrough status” by the FDA. This designation is given to agents intended to treat serious disease if preliminary evidence suggests it provides substantial improvement over existing treatments. Ask your insurance provider whether it covers a Spravato treatment. sublingual, oral, compounded intranasal treatment options are also available.
For those struggling with treatment-resistant depression, Spravato (esketamine) offers a groundbreaking solution. Available at Brain Spa in Noho Los Angeles, CA, this FDA-approved nasal spray provides rapid relief from depressive symptoms, often succeeding where traditional antidepressants have failed. Spravato works differently by targeting NMDA receptors in the brain, helping to alleviate severe depression and giving patients a renewed sense of hope and well-being. Contact us for a consultation today!
Spravato is a nasal spray that contains esketamine, a form of ketamine. It works by targeting the NMDA receptors in the brain, helping to restore neural connections and reduce symptoms of depression, especially in those who haven’t responded to other treatments.
Spravato is administered in a clinical setting under the supervision of a healthcare professional. Patients self-administer the nasal spray, and then remain under observation for about two hours to monitor for any side effects.
Spravato is typically prescribed for adults with treatment-resistant depression, meaning those who have not found relief from at least two different antidepressants. A healthcare provider will determine if Spravato is the right treatment based on your medical history and current condition.